Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_129

McQuade JL et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy. Lancet Oncology 2018;19(3):310–322. Obesity paradox: higher BMI associated with better PFS/OS on ICI + targeted in male advanced-melanoma cohort. [Tasks: 11, 18] Tier: 2 Grade: B Retrieved: 2026-05-07

Evidence grade
B
Tier
2
Cited by tasks
11, 18
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_129/findings.md (research corpus). This page is a short context summary — not individualised medical advice.